Reaction
Pelvic Inflammatory Disease reporting signals
As of the last recalculation, Pelvic Inflammatory Disease appears in 1,478 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is LEVONORGESTREL (PRR 70.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Levonorgestrel | 604 | 70.7 | 70.9 |
| Copper | 148 | 53.6 | 53.8 |
| Misoprostol | 34 | 50.3 | 50.5 |
| Etonogestrel And Ethinyl Estradiol | 46 | 30.1 | 30.2 |
| Metronidazole | 79 | 18.3 | 18.4 |
| Doxycycline Hyclate | 72 | 15.7 | 15.8 |
| Doxycycline | 72 | 15.6 | 15.6 |
| Metronidazole Topical | 45 | 13.7 | 13.7 |
| Ibuprofen And Diphenhydramine Citrate | 18 | 11.0 | 11.0 |
| Nevirapine | 7 | 11.0 | 11.0 |
| Ranolazine | 6 | 8.1 | 8.1 |
| Medroxyprogesterone Acetate | 20 | 5.7 | 5.7 |
| Drospirenone And Ethinyl Estradiol | 16 | 5.1 | 5.1 |
| Ofatumumab | 12 | 5.1 | 5.1 |
| Etonogestrel | 11 | 3.3 | 3.3 |